Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-009464
Filing Date
2025-05-09
Accepted
2025-05-09 16:30:19
Documents
57
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 563912
2 ex31-1.htm EX-31.1 11691
3 ex31-2.htm EX-31.2 11750
4 ex32-1.htm EX-32.1 6203
5 ex32-2.htm EX-32.2 6374
  Complete submission text file 0001641172-25-009464.txt   3159565

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ogen-20250331.xsd EX-101.SCH 27747
7 XBRL CALCULATION FILE ogen-20250331_cal.xml EX-101.CAL 35738
8 XBRL DEFINITION FILE ogen-20250331_def.xml EX-101.DEF 90463
9 XBRL LABEL FILE ogen-20250331_lab.xml EX-101.LAB 271528
10 XBRL PRESENTATION FILE ogen-20250331_pre.xml EX-101.PRE 210411
60 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 301797
Mailing Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236
Business Address 1990 MAIN STREET SUITE 750 SARASOTA FL 34236 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

EIN.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32188 | Film No.: 25930923
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)